StockData

China Pharma Holdings, Inc. (CPHI) stock

CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.54−0.01 (-1.43%)

Close on Nov 11, 2026Market cap $23.37MP/E –Yield –

China Pharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

China Pharma's enterprise value was $23.35M on Nov 11, 2026, against $6.36M a year earlier. Over the last 5 years it ranged from $4.07M to $228.00M, with a median of $32.34M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$23.35M+358.5%
2025Dec 31, 2025$5.09M-87.5%
2024Dec 31, 2024$40.80M+23.3%
2023Dec 29, 2023$33.10M-31.6%
2022Dec 30, 2022$48.36M-78.8%
2021Dec 31, 2021$228.00M+16.5%
2020Dec 31, 2020$195.76M+91.1%
2019Dec 31, 2019$102.43M-8.1%
2018Dec 31, 2018$111.51M+47.9%
2017Dec 29, 2017$75.40M-31.2%
2016Dec 30, 2016$109.66M+71.4%
2015Dec 31, 2015$63.99M-49.4%
2014Dec 31, 2014$126.47M-14.6%
2013Dec 31, 2013$148.02M+80.3%
2012Dec 31, 2012$82.10M-71.4%
2011Dec 30, 2011$286.80M-77.6%
2010Dec 31, 2010$1.28B–

More China Pharma figures

See a number that looks wrong?